Metraipolis › archive › dc_2087fe503274

Immune-tumor cell ligand-receptor axes driving metabolic reprogramming and therapeutic resistance in cancer — Europe PMC PMID:42382771

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42382771
DOI
10.3389/fimmu.2026.1864068
License (as archived)
solo-consultazione
Archived
2026-10-19T09:36:16.242Z
SHA-256 of the archived text
6596e37fdb5db1374d74be013ad074c11c0fc050e7ed24d3063f6c8af85c2031
Stable URL of this page
https://metraipolis.com/documento/dc_2087fe503274

How to cite

Immune-tumor cell ligand-receptor axes driving metabolic reprogramming and therapeutic resistance in cancer — Europe PMC PMID:42382771 — Europe PMC (en), https://europepmc.org/article/MED/42382771 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2087fe503274 (Metraipolis archive dc_2087fe503274, sha256 6596e37fdb5db1374d74be013ad074c11c0fc050e7ed24d3063f6c8af85c2031)
BibTeX
@misc{dc2087fe503274,
  title = {Immune-tumor cell ligand-receptor axes driving metabolic reprogramming and therapeutic resistance in cancer — Europe PMC PMID:42382771},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42382771},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2087fe503274; sha256 6596e37fdb5db1374d74be013ad074c11c0fc050e7ed24d3063f6c8af85c2031},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42382771. Agents can read the archived copy with the MCP tool read_document.